These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17180691)

  • 1. Fasciola hepatica: ultrastructural effects of a combination of triclabendazole and clorsulon against mature fluke.
    Meaney M; Allister J; McKinstry B; McLaughlin K; Brennan GP; Forbes AB; Fairweather I
    Parasitol Res; 2007 Apr; 100(5):1091-104. PubMed ID: 17180691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasciola hepatica: morphological effects of a combination of triclabendazole and clorsulon against mature fluke.
    Meaney M; Allister J; McKinstry B; McLaughlin K; Brennan GP; Forbes AB; Fairweather I
    Parasitol Res; 2006 Oct; 99(5):609-21. PubMed ID: 16896655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes.
    Meaney M; Fairweather I; Brennan GP; McDowell LS; Forbes AB
    Parasitol Res; 2003 Oct; 91(3):238-50. PubMed ID: 12937959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2011 Oct; 109(4):981-95. PubMed ID: 21442257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica.
    Meaney M; Haughey S; Brennan GP; Fairweather I
    Parasitol Res; 2005 Feb; 95(3):201-12. PubMed ID: 15645289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Vet Parasitol; 2012 Feb; 184(1):37-47. PubMed ID: 21872399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2010 May; 106(6):1351-63. PubMed ID: 20336319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Vet Parasitol; 2011 May; 177(3-4):305-15. PubMed ID: 21208747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
    McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
    Parasitology; 2006 Aug; 133(Pt 2):195-208. PubMed ID: 16650337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of vitellogenesis and spermatogenesis by triclabendazole (TCBZ) in a TCBZ-resistant isolate of Fasciola hepatica following incubation in vitro with a P-glycoprotein inhibitor.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2014 Jul; 141(8):1064-79. PubMed ID: 24889697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the comparative efficacy of a moxidectin plus triclabendazole pour-on solution against adult and immature liver fluke, Fasciola hepatica, in cattle.
    Geurden T; Bartram D; Van Brussel L; Bo L; Scott-Baird E; Rugg D
    Vet Parasitol; 2012 Oct; 189(2-4):227-32. PubMed ID: 22579500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.
    Meaney M; Savage J; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2013 Sep; 140(10):1287-303. PubMed ID: 23756576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitology; 2011 Feb; 138(2):224-36. PubMed ID: 20946692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the P-glycoprotein inhibitor, R(+)-verapamil on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Vet Parasitol; 2013 Jul; 195(1-2):72-86. PubMed ID: 23597772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission electron microscope study of the ultrastructural changes induced in the tegument and gut of Fasciola hepatica following in vivo drug treatment with clorsulon.
    Meaney M; Fairweather I; Brennan GP; Forbes AB
    Parasitol Res; 2004 Feb; 92(3):232-41. PubMed ID: 14714178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an anthelmintic combination in sheep infected with Fasciola hepatica resistant to albendazole and clorsulon.
    Martínez-Valladares M; Cordero-Pérez C; Rojo-Vázquez FA
    Exp Parasitol; 2014 Jan; 136():59-62. PubMed ID: 24211419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
    Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.
    O'Neill JF; Johnston RC; Halferty L; Brennan GP; Keiser J; Fairweather I
    J Helminthol; 2009 Jun; 83(2):151-63. PubMed ID: 19368748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.